Does substance use compromise depression treatment in persons with HIV? Findings from a randomized controlled trialFootnote^†

† Portions of this paper were presented earlier in poster form at the Conference on Retroviruses and Opportunistic Infections, Boston, Massachusetts USA, March 2014.

References

• Adams, C., Zacharia, S., Masters, L., Coffey, C., & Catalan, P. (2016). Mental health problems in people living with HIV: Changes in the last two decades: The London experience 1990–2014. AIDS Care, 1–4. doi:10.1080/09540121.2016.1146211
   Web of Science ®Google Scholar
• Akincigil, A., Bowblis, J. R., Levin, C., Walkup, J. T., Jan, S., & Crystal, S. (2007). Adherence to antidepressant treatment among privately insured patients diagnosed with depression. Medical Care, 45(4), 363–369. doi:10.1097/01.mlr.0000254574.23418.f6
   PubMed Web of Science ®Google Scholar
• Azar, M. M., Springer, S. a., Meyer, J. P., & Altice, F. L. (2010). A systematic review of the impact of alcohol use disorders on HIV treatment outcomes, adherence to antiretroviral therapy and health care utilization. Drug and Alcohol Dependence, 112(3), 178–193. doi:10.1016/j.drugalcdep.2010.06.014
   PubMed Web of Science ®Google Scholar
• Bing, E. G., Burnam, M. A., Longshore, D., Fleishman, J. A., Sherbourne, C. D., London, A. S., … Shapiro, M. (2001). Psychiatric disorders and drug use among human immunodeficiency virus-infected adults in the United States. Archives of General Psychiatry, 58(8), 721–728. doi: 10.1001/archpsyc.58.8.721
   PubMed Web of Science ®Google Scholar
• Blashill, A. J., Bedoya, C. A., Mayer, K. H., O’Cleirigh, C., Pinkston, M. M., Remmert, J. E., … Safren, S. A. (2015). Psychosocial syndemics are additively associated with worse ART adherence in HIV-infected individuals. AIDS and Behavior, 19(6), 981–986. doi:10.1007/s10461-014-0925-6
   PubMed Web of Science ®Google Scholar
• Burnam, M. A., Bing, E. G., Morton, S. C., Sherbourne, C., Fleishman, J. A., London, A. S., … Shapiro, M. F. (2001). Use of mental health and substance abuse treatment services among adults with HIV in the United States. Archives of General Psychiatry, 58(8), 729–736. doi: 10.1001/archpsyc.58.8.729
   PubMed Web of Science ®Google Scholar
• Carrico, A. W., Riley, E. D., Johnson, M. O., Charlebois, E. D., Neilands, T. B., Remien, R. H., … Chesney, M. A. (2011). Psychiatric risk factors for HIV disease progression: The role of inconsistent patterns of antiretroviral therapy utilization. Journal of Acquired Immune Deficiency Syndromes (1999), 56(2), 146–150. doi:10.1097/QAI.0b013e318201df63
   PubMedGoogle Scholar
• Cook, J. A., Burke-Miller, J. K., Cohen, M. H., Cook, R. L., Vlahov, D., Wilson, T. E., … Grey, D. D. (2008). Crack cocaine, disease progression, and mortality in a multicenter cohort of HIV-1 positive women. AIDS (London, England), 22(11), 1355–1363. doi:10.1097/QAD.0b013e32830507f2
   PubMed Web of Science ®Google Scholar
• Davis, L. L., Pilkinton, P., Wisniewski, S. R., Trivedi, M. H., Gaynes, B. N., Howland, R. H., … Rush, A. J. (2012). Effect of concurrent substance use disorder on the effectiveness of single and combination antidepressant medications for the treatment of major depression: An exploratory analysis of a single-blind randomized trial. Depression and Anxiety, 29(2), 111–122. doi:10.1002/da.20918
   PubMed Web of Science ®Google Scholar
• Durvasula, R., & Miller, T. R. (2014). Substance abuse treatment in persons with HIV/AIDS: Challenges in managing triple diagnosis. Behavioral Medicine, 40(2), 43–52. doi:10.1080/08964289.2013.866540
   PubMed Web of Science ®Google Scholar
• Fazel, S., Khosla, V., Doll, H., & Geddes, J. (2008). The prevalence of mental disorders among the homeless in western countries: Systematic review and meta-regression analysis. PLoS Medicine, 5(12), e225. doi:10.1371/journal.pmed.0050225
   PubMed Web of Science ®Google Scholar
• Friedman, M. R., Stall, R., Plankey, M., Wei, C., Shoptaw, S., Herrick, A., … Silvestre, A. J. (2015). Effects of syndemics on HIV viral load and medication adherence in the multicentre AIDS cohort study. AIDS (London, England), 29(9), 1087–1096. doi:10.1097/QAD.0000000000000657
   PubMed Web of Science ®Google Scholar
• Galvan, F. H., Bing, E. G., Fleishman, J. A., London, A. S., Caetano, R., Burnam, M. A., … Shapiro, M. (2002). The prevalence of alcohol consumption and heavy drinking among people with HIV in the United States: Results from the HIV cost and services utilization study. Journal of Studies on Alcohol, 63(2), 179–186. doi: 10.15288/jsa.2002.63.179
   PubMed Web of Science ®Google Scholar
• Hobbs, J. D. J., Kushner, M. G., Lee, S. S., Reardon, S. M., & Maurer, E. W. (2011). Meta-analysis of supplemental treatment for depressive and anxiety disorders in patients being treated for alcohol dependence. The American Journal on Addictions/American Academy of Psychiatrists in Alcoholism and Addictions, 20(4), 319–329. doi:10.1111/j.1521-0391.2011.00140.x
   PubMed Web of Science ®Google Scholar
• Horberg, M. A., Silverberg, M. J., Hurley, L. B., Towner, W. J., Klein, D. B., Bersoff-Matcha, S., … Kovach, D. A. (2008). Effects of depression and selective serotonin reuptake inhibitor use on adherence to highly active antiretroviral therapy and on clinical outcomes in HIV-infected patients. Journal of Acquired Immune Deficiency Syndromes, 47(3), 384–390. doi:10.1097/QAI.0b013e318160d53e
   PubMed Web of Science ®Google Scholar
• Iovieno, N., Tedeschini, E., Bentley, K. H., Evins, A. E., & Papakostas, G. I. (2011). Antidepressants for major depressive disorder and dysthymic disorder in patients with comorbid alcohol use disorders: A meta-analysis of placebo-controlled randomized trials. The Journal of Clinical Psychiatry, 72(8), 1144–1151. doi:10.4088/JCP.10m06217
   PubMed Web of Science ®Google Scholar
• Kenya, S., Chida, N., Jones, J., Alvarez, G., Symes, S., & Kobetz, E. (2013). Weekending in PLWH: Alcohol use and ART adherence, a pilot study. AIDS and Behavior, 17(1), 61–67. doi:10.1007/s10461-012-0307-x
   PubMed Web of Science ®Google Scholar
• Koegel, P., Sullivan, G., Burnam, A., Morton, S. C., & Wenzel, S. (1999). Utilization of mental health and substance abuse services among homeless adults in Los Angeles. Medical Care, 37(3), 306–317. doi: 10.1097/00005650-199903000-00010
   PubMed Web of Science ®Google Scholar
• Lucas, G. M., Gebo, K. A., Chaisson, R. E., & Moore, R. D. (2002). Longitudinal assessment of the effects of drug and alcohol abuse on HIV-1 treatment outcomes in an urban clinic. AIDS (London, England), 16(5), 767–774. doi: 10.1097/00002030-200203290-00012
   PubMed Web of Science ®Google Scholar
• Mimiaga, M. J., O'Cleirigh, C., Biello, K. B., Robertson, A. M., Safren, S. A., Coates, T. J., … Mayer, K. H. (2015). The effect of psychosocial syndemic production on 4-year HIV incidence and risk behavior in a large cohort of sexually active men who have sex with men. JAIDS Journal of Acquired Immune Deficiency Syndromes, 68(3), 329–336. doi:10.1097/QAI.0000000000000475
   PubMed Web of Science ®Google Scholar
• Moss, A. R., Hahn, J. A., Perry, S., Charlebois, E. D., Guzman, D., Clark, R. A., & Bangsberg, D. R. (2004). Adherence to highly active antiretroviral therapy in the homeless population in San Francisco: A prospective study. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America, 39(8), 1190–1198. doi:10.1086/424008
   PubMed Web of Science ®Google Scholar
• Nunes, E. V., & Levin, F. R. (2004). Treatment of depression in patients with alcohol or other drug dependence: A meta-analysis. JAMA, 291(15), 1887–1896. doi:10.1001/jama.291.15.1887
   PubMed Web of Science ®Google Scholar
• Oliveto, A., Poling, J., Mancino, M. J., Williams, D. K., Thostenson, J., Pruzinsky, R., … Kosten, T. R. (2012). Sertraline delays relapse in recently abstinent cocaine-dependent patients with depressive symptoms. Addiction (Abingdon, England), 107(1), 131–141. doi:10.1111/j.1360-0443.2011.03552.x
   PubMed Web of Science ®Google Scholar
• Pettinati, H. M., O’Brien, C. P., & Dundon, W. D. (2013). Current status of co-occurring mood and substance use disorders: A new therapeutic target. The American Journal of Psychiatry, 170(1), 23–30. doi:10.1176/appi.ajp.2012.12010112
   PubMed Web of Science ®Google Scholar
• Prince, M., Patel, V., Saxena, S., Maj, M., Maselko, J., Phillips, M. R., & Rahman, A. (2007). No health without mental health. Lancet, 370(9590), 859–877. doi:10.1016/S0140-6736(07)61238-0
   PubMed Web of Science ®Google Scholar
• Rabkin, J. G., Wagner, G. J., & Rabkin, R. (1999). Fluoxetine treatment for depression in patients with HIV and AIDS: A randomized, placebo-controlled trial. The American Journal of Psychiatry, 156(1), 101–107. doi: 10.1176/ajp.156.1.101
   PubMed Web of Science ®Google Scholar
• Robertson, M. J., Clark, R. A., Charlebois, E. D., Tulsky, J., Long, H. L., Bangsberg, D. R., & Moss, A. R. (2004). HIV seroprevalence among homeless and marginally housed adults in San Francisco. American Journal of Public Health, 94(7), 1207–1217. doi: 10.2105/AJPH.94.7.1207
   PubMed Web of Science ®Google Scholar
• Schuckit, M. A., Tipp, J. E., Bergman, M., Reich, W., Hesselbrock, V. M., & Smith, T. L. (1997). Comparison of induced and independent major depressive disorders in 2,945 alcoholics. The American Journal of Psychiatry, 154(7), 948–957. doi:10.1176/ajp.154.7.948
   PubMed Web of Science ®Google Scholar
• Shoptaw, S., Huber, A., Peck, J., Yang, X., Liu, J., Jeff, D., … Ling, W. (2006). Randomized, placebo-controlled trial of sertraline and contingency management for the treatment of methamphetamine dependence. Drug and Alcohol Dependence, 85(1), 12–18. doi:10.1016/j.drugalcdep.2006.03.005
   PubMed Web of Science ®Google Scholar
• Stall, R., Coulter, R. W. S., Friedman, M. R., & Plankey, M. W. (2015). Commentary on “syndemics of psychosocial problems and HIV risk: A systematic review of empirical tests of the disease interaction concept” by A. Tsai and B. Burns. Social Science and Medicine, 145, 129–131. doi:10.1016/j.socscimed.2015.07.016
   PubMed Web of Science ®Google Scholar
• Tegger, M. K., Crane, H. M., Tapia, K. A., Uldall, K. K., Holte, S. E., & Kitahata, M. M. (2008). The effect of mental illness, substance use, and treatment for depression on the initiation of highly active antiretroviral therapy among HIV-infected individuals. AIDS Patient Care and STDs, 22(3), 233–243. doi:10.1089/apc.2007.0092
   PubMed Web of Science ®Google Scholar
• Torrens, M., Fonseca, F., Mateu, G., & Farré, M. (2005). Efficacy of antidepressants in substance use disorders with and without comorbid depression: A systematic review and meta-analysis. Drug and Alcohol Dependence, 78, 1–22. doi:10.1016/j.drugalcdep.2004.09.004
   PubMed Web of Science ®Google Scholar
• Tsai, A. C., Karasic, D. H., Hammer, G. P., Charlebois, E. D., Ragland, K., Moss, A. R., … Bangsberg, D. R. (2013). Directly observed antidepressant medication treatment and HIV outcomes among homeless and marginally housed HIV-positive adults: A randomized controlled trial. American Journal of Public Health, 103(2), 308–315. doi:10.2105/AJPH.2011.300422
   PubMed Web of Science ®Google Scholar
• Tsai, A. C., Mimiaga, M. J., Dilley, J. W., Hammer, G. P., Karasic, D. H., Charlebois, E. D., … Bangsberg, D. R. (2013). Does effective depression treatment alone reduce secondary HIV transmission risk? Equivocal findings from a randomized controlled trial. AIDS and Behavior, 17(8), 2765–2772. doi:10.1007/s10461-013-0600-3
   PubMed Web of Science ®Google Scholar
• Tsai, A. C., Weiser, S. D., Petersen, M. L., Ragland, K., Kushel, M. B., & Bangsberg, D. R. (2010). A marginal structural model to estimate the causal effect of antidepressant medication treatment on viral suppression among homeless and marginally housed persons with HIV. Archives of General Psychiatry, 67(12), 1282–1290. doi:10.1001/archgenpsychiatry.2010.160
   PubMed Web of Science ®Google Scholar
• Tucker, J. S., Burnam, M. A., Sherbourne, C. D., Kung, F.-Y., & Gifford, A. L. (2003). Substance use and mental health correlates of nonadherence to antiretroviral medications in a sample of patients with human immunodeficiency virus infection. The American Journal of Medicine, 114(7), 573–580. doi:10.1016/S0002-9343(03)00093-7
   PubMed Web of Science ®Google Scholar
• Vos, T., Flaxman, A. D., Naghavi, M., Lozano, R., Michaud, C., Ezzati, M., … Memish, Z. A. (2012). Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: A systematic analysis for the global burden of disease study 2010. Lancet, 380(9859), 2163–2196. doi:10.1016/S0140-6736(12)61729-2
   PubMed Web of Science ®Google Scholar
• Watkins, K. E., Burnam, A., Kung, F. Y., & Paddock, S. (2001). A national survey of care for persons with co-occurring mental and substance use disorders. Psychiatric Services (Washington, D.C.), 52(8), 1062–1068. doi:10.1176/appi.ps.52.8.1062
   PubMed Web of Science ®Google Scholar
• Zimmerman, M., Mattia, J. I., & Posternak, M. A. (2002). Are subjects in pharmacological treatment trials of depression representative of patients in routine clinical practice? American Journal of Psychiatry, 159, 469–473. doi:10.1176/appi.ajp.159.3.469
   PubMed Web of Science ®Google Scholar
• Zisook, S., Peterkin, J., Goggin, K. J., Sledge, P., Atkinson, J. H., & Grant, I. (1998). Treatment of major depression in HIV-seropositive men. HIV Neurobehavioral Research Center Group. The Journal of Clinical Psychiatry, 59(5), 217–224.
   PubMed Web of Science ®Google Scholar
• Zolopa, A. R., Hahn, J. A., Gorter, R., Miranda, J., Wlodarczyk, D., Peterson, J., … Moss, A. R. (1994). HIV and tuberculosis infection in San Francisco’s homeless adults. Prevalence and risk factors in a representative sample. JAMA, 272(6), 455–461. doi: 10.1001/jama.1994.03520060055032
   PubMed Web of Science ®Google Scholar